HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilbur A Franklin Selected Research

Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)

7/2013Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
9/2008A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
4/2006Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
10/2005Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
6/2004Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.
10/2003Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wilbur A Franklin Research Topics

Disease

38Neoplasms (Cancer)
01/2019 - 05/2002
35Lung Neoplasms (Lung Cancer)
11/2020 - 02/2002
33Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2019 - 02/2002
8Carcinogenesis
03/2011 - 05/2002
6Carcinoma (Carcinomatosis)
01/2019 - 07/2002
6Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
07/2013 - 10/2003
5Adenocarcinoma
07/2013 - 02/2002
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2016 - 05/2002
4Breast Neoplasms (Breast Cancer)
06/2004 - 02/2002
3Colorectal Neoplasms (Colorectal Cancer)
03/2009 - 04/2008
3Chronic Obstructive Pulmonary Disease (COPD)
11/2007 - 01/2004
2Adenocarcinoma of Lung
02/2015 - 07/2013
2Sarcoma (Soft Tissue Sarcoma)
02/2015 - 09/2012
2Hypoxia (Hypoxemia)
06/2009 - 10/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2003 - 02/2002
1Inflammation (Inflammations)
01/2018
1Lymphocytosis
01/2018
1Esophageal Neoplasms (Esophageal Cancer)
01/2017
1Neuroblastoma
02/2015
1Genomic Instability
02/2014
1Disease Progression
09/2011
1Ovarian Neoplasms (Ovarian Cancer)
01/2011
1Tobacco Use Disorder (Nicotine Dependence)
05/2010
1Pleural Effusion (Pleural Effusions)
09/2008
1Melanoma (Melanoma, Malignant)
12/2006

Drug/Important Bio-Agent (IBA)

28ErbB Receptors (EGF Receptor)IBA
06/2019 - 02/2002
17Biomarkers (Surrogate Marker)IBA
01/2019 - 07/2002
14Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2002
11Gefitinib (Iressa)FDA Link
01/2011 - 05/2005
8Tyrosine Kinase InhibitorsIBA
06/2019 - 08/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2016 - 01/2004
5Anaplastic Lymphoma KinaseIBA
02/2015 - 11/2010
5Cetuximab (Erbitux)FDA Link
11/2010 - 07/2008
5Monoclonal AntibodiesIBA
03/2009 - 02/2002
4Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 10/2008
4Trastuzumab (Herceptin)FDA Link
08/2003 - 02/2002
3Messenger RNA (mRNA)IBA
11/2020 - 05/2006
3AntigensIBA
10/2017 - 07/2002
3PlatinumIBA
11/2013 - 10/2008
3Pharmaceutical PreparationsIBA
07/2013 - 03/2009
3Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2013 - 08/2004
3Carboplatin (JM8)FDA LinkGeneric
09/2011 - 10/2008
3Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2011 - 12/2006
3Urethane (Ethyl Carbamate)IBA
03/2011 - 08/2003
3Biological ProductsIBA
09/2008 - 05/2006
2Folic Acid (Vitamin M)FDA LinkGeneric
07/2013 - 04/2008
2CarcinogensIBA
03/2011 - 12/2005
2Indicators and Reagents (Reagents)IBA
04/2010 - 08/2005
2CytokinesIBA
06/2009 - 08/2004
2Panitumumab (Vectibix)FDA Link
03/2009 - 03/2009
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2006 - 05/2005
2Epidermal Growth Factor (EGF)IBA
05/2005 - 08/2003
2RNA (Ribonucleic Acid)IBA
04/2005 - 07/2002
2beta CateninIBA
01/2005 - 10/2002
2OligonucleotidesIBA
02/2004 - 07/2002
1B7-H1 AntigenIBA
01/2019
1LigandsIBA
01/2019
1MucinsIBA
01/2018
1EpitopesIBA
01/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2017
1AutoantibodiesIBA
01/2017
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1human ERBB2 proteinIBA
02/2015
1MAP Kinase Kinase 1IBA
02/2015
1Docetaxel (Taxotere)FDA Link
11/2013
1Vinorelbine (Navelbine)FDA LinkGeneric
11/2013
1Platinum Compounds (Compounds, Platinum)IBA
11/2013
1Pemetrexed (MTA)FDA Link
07/2013
1Folic Acid AntagonistsIBA
07/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2013
1MicroRNAs (MicroRNA)IBA
02/2013
1Formaldehyde (Formol)FDA Link
02/2013
1CrizotinibIBA
03/2012
1CreatinineIBA
09/2011
1Iloprost (Ventavis)FDA Link
06/2011
1Protein Kinase CIBA
03/2011
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2010
1EnzymesIBA
05/2010
1NicotineFDA Link
05/2010
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
05/2010
1ORALIT (ORS)IBA
04/2010
1ParaffinIBA
01/2010
1Transcription Factors (Transcription Factor)IBA
06/2009
1ElementsIBA
06/2009
1alpha-TocopherolFDA Link
05/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2009
1Tirapazamine (SR 4233)IBA
10/2008
1Cytotoxins (Cytolysins)IBA
10/2008
1OsteopontinIBA
10/2008
1Folate Receptor 1IBA
04/2008
1AntibodiesIBA
03/2008
1Complement System Proteins (Complement)IBA
01/2008
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2006

Therapy/Procedure

21Therapeutics
06/2019 - 05/2002
9Drug Therapy (Chemotherapy)
11/2013 - 06/2004
8Chemoprevention
02/2013 - 02/2002
2Immunotherapy
01/2019 - 10/2017
2Lasers (Laser)
04/2011 - 12/2005
1Microspheres (Microsphere)
01/2017